1Puehner W,Obwegeser J,Puhringer FK Use of remifentanil for awake fiberoptic intubation in a morbidly obese patient with severe inflammation of the neck.Acta Anaesthesiol Scand,2002,46:473-476.
5Selcuk M,Celebioglu B,Celiker V,et al.Infusion and bolus administration of dsatracurium-effects on histamine release.Middie East J Anesthesiol,2005,18:407-419.
6Belment MR,Lien CA.Quessy S,et al.The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/babiturate anesthesia.Ansthesiology,1995,82:1139-1145.
7Meakin GH,Meretoja OA,Perkins RJ.Tracheal intubating conditions and pharmadynamics following cisatracurium in infants and children undergoing halothane and thiopental-fentanyl anesthesia.Paediatr Anaesth,2007,17:113-120.
2Arain SR, Kern S, Ficke DJ, et al. Variability of duration of action of neuromuscular blocking drugs in elderly patients. Acta Anaesthesiol Scand, 2005,49 : 312-315.
3Krieg N, Mazur L, Booij LH, et al. Intubation conditions and reversibility of a new non-depolarizing neuromuscular blocking agent, Org-NC4s. Acta Anesthesiology Seand, 1980, 24: 423- 425.
4Rosow CE, Basta SJ, Savarese JJ, et al. Correlation of cardiovascular effects with increases in plasma histamineC J]. Anesthesiology,1980, 53 : S270.
5Verburg KM, Bowsher RR, Henry DP. A new radioenzymatic assay for histamine using purified histamine N-methyltransferase [ J ]. Life Scienses, 1983, 32:2855 -2867.
6Moss J. Muscle relaxants and histamine release[ J]. Acta Anaesthesiol Scand, 1995, 106 (Suppl) : 7 - 12.
7Belmont MR, Lien CA, Quassy S, et aL The clinic neuromuscular pharmacology of 51 W89 in patients receiving nitrous oxide/opioid/barbiturate anaesthesia [ J ]. Anesthesiology, 1995, 82:1139 -1145.
8Litdejohn IH, Abhay K, El Sayed PJ. Intubating conditions following 1R cis -1' R cis atracurium (51W89) [ J ]. Anaesthesia, 1995,50:499 - 502.
9Boyd AH, Eastwood, NB, Parker CJR, et al. Pharmaco - dynamics of the 1R cis - 1' R cis isomer of atracurium ( 51 W89 ) in health and chronic renal failure[J]. Br J Anaesth, 1995, 74:400 -404.
10Basta S J, Savarese JJ, Ali HH, et al. Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine [ J]. Br J Anaesth, 1983, 55:105S-106S.
4Bevan DR. Recovery from neuromuscular block and its assessment [ J ]. Anesth Analg, 2000,90 ( 5 Suppl ) : $7 - S13.
5Ali HH, Wilson RS, Savarese J J, et al. The effect of tu- bocurarine on indirectly elicited train - of - four mus- cle response and respiratory measurements in humans [ J ]. Br J Anesthesiology, 1975,47 (5) :570 - 574.
6Kopman AF, Yee PS, Neuman G. Relationship of the train - of - four fade ratio toclinical signs and symp- toms of residual paralysis in awake volunteers[ J ]. An- esthesiology, 1997,86(4) :765 - 771.
8Cammu G, de - Baerdemaeker L, den - Blauwen N, et al. Postoperative re - sidual curarization with cisatra- curium and rocuronium infusions [ J ]. Eur J Auesth, 2002,19 : 129 - 134.
9Moosa Mirinejad, Rasoul Azarfarin, Azin Alizadeh Asl. Cisatracurium in cardiac surgery - Continuous infu- sion vs bolus administration[ J]. MEJ Anesth,2007, 19(3) :563 -572.
10Meakin George H,Meretoja Olli A,Perkins Russell J,Waite Ian,Taivainen Tomi,Wirtavuori Kari,Murphy Anthony K,Raiha Leena.Tracheal intubating conditions and pharmacodynamics following cisatracurium in infants and children undergoing halothane and thiopental-fentanyl anesthesia. Paediatric Anaesthesia . 2007
